Non-small cell lung carcinoma (NSCLC) harboring rearrangements of the anaplastic lymphoma kinase (ALK) gene and the ROS1 oncogene constitute a unique molecular subgroup of this patient population. The gene discussed is ALK; the disease is non-small cell lung carcinoma.